Asuma Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.15 Cr
- Paid Up Capital ₹ 6.76 M
- Company Age 23 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
About Asuma Biotech
Asuma Biotech Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 November 2001 and has a history of 23 years and two months. Its registered office is in Delhi, India.
The Company is engaged in the Musical Instruments Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.15 Cr and a paid-up capital of Rs 6.76 M, as per Ministry of Corporate Affairs (MCA) records.
Krishan Sharma and Rajesh Rawat serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231DL2001PTC113295
-
Company No.
113295
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Nov 2001
-
Date of AGM
07 Aug 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Asuma Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Rawat
|
Director | 31-Jul-2019 | Current |
|
Krishan Sharma
|
Director | 30-Sep-2013 | Current |
Financial Performance of Asuma Biotech.
Asuma Biotech Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Asuma Biotech?
In 2017, Asuma Biotech had a public holding of 100.00%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Global Medikit LimitedKrishan Sharma is a mutual person
-
Siltech Engineering Private LimitedKrishan Sharma is a mutual person
-
Savariya Investments Private Limited
Krishan Sharma is a mutual person
-
Prichsit Investments Private Limited
Krishan Sharma is a mutual person
-
Indeco Engineering Pvt. Ltd.
Krishan Sharma is a mutual person
-
Intermedical Systems Private Limited
Rajesh Rawat is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Asuma Biotech?
Unlock and access historical data on people associated with Asuma Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Asuma Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asuma Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
